We recently published a list of 10 Firms Defy Market Slump, Record Double-Digit Gains Last Week. In this article, we are ...

After biotechnology and genetic engineering company Colossal Biosciences said it successfully created three dire wolf puppies ...

A company recently claimed it revived an extinct species, launching a debate across scientific and conservation communities.

Recursion Pharmaceuticals (RXRX) shares closed up 27% after the Food and Drug Administration (FDA) said it wants to phase out ...

Certara’s AI strategy and FDA-aligned offerings fuel growth across drug discovery and trials, with expanding margins. Read ...

The initiative, which will start with monoclonal antibodies, is the first big regulatory shift from the FDA since Martin ...

Colossal Bioscience says it has “de-extincted” the dire wolf, but other scientists disagree and say more important ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Friday after the U.S. Food and Drug ...

The recent claim the long extinct dire wolf was resurrected made headlines around the world. But bioethicists and ecologists ...

Mites are common in the Antarctic – there are hundreds of species. Some even live in the nasal cavities of penguins. Penguin ...

Through gene editing, scientists at Colossal Biosciences are reviving long-extinct animals. But is it really for the sake of ...

Immediate use for the newly developed assembloids could include studying neurodevelopmental disorders such as autism.